Biocompatible reactive oxygen species (ROS)-responsive nanoparticles as superior drug delivery vehicles.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25147049.
- Also identified by DOI 10.1002/adhm.201400299.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A novel reactive oxygen species (ROS)-responsive nanoplatform can be successfully manufactured from a ROS-triggerable β-cyclodextrin material. Extensive in vitro and in vivo studies validate that this nanoscaled system may serve as a new drug delivery vehicle with well-defined ROS-sensitivity and superior biocompatibility. This nanocarrier can be used for ROS-triggered transport of diverse therapeutics and imaging agents.
Medical subject headings
- Biocompatible Materials
- Drug Carriers
- Materials Testing
- Nanoparticles
- Reactive Oxygen Species